Day: February 23, 2021

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, continues to exhibit a leading presence at the Cutting Edge of Transplantation (CEoT) Meeting, February 25-27, 2021, with leading institutions sharing AlloSure donor-derived cell-free DNA (dd-cfDNA) data in both poster presentations and symposium.CareDx will host a lunch symposium on Thursday, February 25, titled “AlloSure and Relative Change Value.” Moderated by Vinaya Rao, MD, MUSC. The program showcases an impressive line-up of speakers which includes:Gaurav Gupta, MD, VCU, presenting the results from the ADMIRAL study which validates AlloSure’s...

VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (the “Company” or “Calibre”) is pleased to provide an update in respect of the Company’s 2020 drilling program, highlighting the new Atravesada underground zones at Limon where no current gold resource is reported. The 2020 resource expansion and infill drilling programs will lead to significant reserve increases at Limon and Libertad when the Company reports at the end of the first quarter of 2021. Calibre’s 2021 exploration program is now well underway and is expected to include approximately 60,000 metres of drilling.   New Resource Opportunity HighlightsAtravesada Underground Zones (Limon Complex)7.98 g/t Au over 6.8 metres Estimated True Width (“ETW”) from 232.0 metres (LIM-20-4497)3.64 g/t Au over 8.2 metres ETW...

MALVERN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced the signing of an amendment to its existing credit facility with funds managed by Athyrium Capital Management, LP (Athyrium), a leading healthcare-focused investment firm. Under terms of the amendment, among other items, the credit facility’s outstanding debt balance has been reduced from $116 million to $100 million and the interest rate governing the facility has been decreased by 1.5 percent. Furthermore, there will be no additional principal amortization during the remainder of the term of the facility, which runs through March 2023. Athyrium...

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Shaul Eyal has joined the Company’s equity research team to cover cybersecurity and information security stocks. He will report to Robert Fagin, Cowen’s Head of Research.“Cybersecurity is one of the most critical macro investment themes today,” said Robert Fagin. “We are thrilled to have someone with Shaul’s industry knowledge and connectivity join the Cowen Research platform.”Cowen’s research department has 55 senior analysts covering over 800 securities across multiple sectors including capital goods & industrials, consumer, energy and sustainability, health care, technology, media & telecom, as well as a deep Washington policy team.Prior to joining Cowen, Mr. Eyal spent over two decades covering the software...

I medfør af kapitalmarkedsloven § 24, oplyser DLR Kredit A/S hermed om udtrækninger (CK95) pr. fredag den 19. februar 2021. Oplysningerne fremgår af vedhæftede fil.Denne meddelelse er offentliggjort med henblik på opfyldelse af transparensdirektivets krav om offentliggørelse.Udtrækningen foretages efter den nye udtrækningsmodel på danske obligationer, jf. https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=660805&lang=da. Dette betyder, at meddelelsen ikke indeholder oplysninger om cirkulerende mængde og udtrækningsprocent.Med venlig hilsenVedhæftet filCK95-19022021_01052021

ANN ARBOR, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company received its first small shipment of spider silk from Prodigy textiles, its wholly-owned Vietnamese subsidiary.The Company has received fiber requests from a broad range of interested parties, including companies that produce products in the fields of sports apparel, industrial textiles, first responder supplies, medical products, and other manufacturers. In order to meet this demand, the Company established Prodigy Textiles to scale up the production of its recombinant spider silk fibers, threads, and textiles.The Company’s operations at its Prodigy Textiles facility are now moving...

ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021:Cowen 41st Annual Health Care ConferenceBlazing New Paths in Clinical Development and Structure PanelTuesday, March 2, 2021 at 2:10 pm ET33rd Annual ROTH ConferenceOphthalmology PanelTuesday, March 16, 2021 at 9:00 am ETThe panels will be available for attendees on the conference websites. Management will be participating in live, virtual one-on-one meetings with investors who are registered to attend the conferences.About Clearside BiomedicalClearside Biomedical, Inc. is a biopharmaceutical...

Næstbedste afkast i Handelsinvests historieDet samlede resultat i 2020 i foreningen blev et overskud på 1.932 mio. kr. mod et overskud på 2.189 mio. kr. i 201915 ud af vores 16 afdelinger fik positive afkast.Hvor 2019 huskes for et ualmindeligt godt år for investorer, så kommer vi næppe udenom, at 2020 primært huskes for Covid-19. Ikke engang et ganske ualmindeligt amerikansk præsidentvalg kunne overskygge Covid-19´s betydning for økonomien, investeringer og borgeres sociale liv m.m., men samlet set blev 2020 endnu et rigtig godt år i Handelsinvest.I 2020 er omkostningerne i gennemsnit faldet fra 0,79% i 2019 til 0,76% i 2020. Faldet skyldes stigende formue og at andelen af investeringer i andelsklasser uden formidlingsprovision er øget. Foreningens samlede omkostningsprocent er faldet fra 1,57% i 2010 til 0,76% i 2020 og er dermed mere...